Published in Naunyn Schmiedebergs Arch Pharmacol on January 06, 2010
Modulation of the Surgical Inflammatory Response by Etoricoxib | NCT00746720
Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief. Eur J Pain (2011) 0.85
Using pharmacokinetic principles to optimize pain therapy. Nat Rev Rheumatol (2010) 0.83
Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib. BMC Musculoskelet Disord (2015) 0.77
Studies with pain rating scales. Ann Rheum Dis (1978) 6.97
Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature (2001) 4.82
Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg (1993) 4.03
Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology (2006) 2.36
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther (1994) 1.79
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther (2001) 1.65
Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med (2002) 1.42
Single dose oral etoricoxib for acute postoperative pain in adults. Cochrane Database Syst Rev (2009) 1.42
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest (2005) 1.30
Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. J Pharmacol Exp Ther (2005) 1.23
Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. Anesthesiology (2005) 1.16
Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics. Adv Drug Deliv Rev (2004) 1.15
Upregulation of spinal cyclooxygenase-2 in rats after surgical incision. Anesthesiology (2004) 1.03
Liquid chromatographic-mass spectrometric determination of cyclooxygenase metabolites of arachidonic acid in cultured cells. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.00
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. Br J Pharmacol (2005) 0.99
Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity. J Pharmacol Exp Ther (2004) 0.98
Selective cyclooxygenase-2 inhibitors: similarities and differences. Scand J Rheumatol (2004) 0.95
The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity. Curr Med Res Opin (2002) 0.95
Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings. Clin Pharmacol Ther (1998) 0.94
Characterization of etoricoxib, a novel, selective COX-2 inhibitor. J Clin Pharmacol (2003) 0.94
Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man. J Clin Pharmacol (2003) 0.91
The classification of cyclooxygenase inhibitors. J Rheumatol (1998) 0.91
Pharmacokinetics of etoricoxib in patients with hepatic impairment. J Clin Pharmacol (2003) 0.89
Cyclooxygenase-2 inhibition potentiates morphine antinociception at the spinal level in a postoperative pain model. Reg Anesth Pain Med (2002) 0.89
LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.89
Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand (2002) 0.89
Transient up-regulation of spinal cyclooxygenase-2 and neuronal nitric oxide synthase following surgical inflammation. Anesthesiology (2003) 0.88
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. J Clin Pharmacol (2008) 0.88
Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study. Anesth Analg (2005) 0.88
Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal. Nat Clin Pract Rheumatol (2007) 0.87
Plasma and tissue binding considerations in drug disposition. Drug Metab Rev (1983) 0.87
Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects. Eur J Pharmacol (2007) 0.86
Etoricoxib for pain management during thyroid surgery--a prospective, placebo-controlled study. Otolaryngol Head Neck Surg (2008) 0.82
Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty. Acta Anaesthesiol Scand (2006) 0.81
Cerebrospinal fluid and plasma pharmacokinetics of the cyclooxygenase 2 inhibitor rofecoxib in humans: single and multiple oral drug administration. Anesth Analg (2005) 0.81
Spinal synthesis and release of prostanoids after peripheral injury and inflammation. Adv Exp Med Biol (1999) 0.80
Nonsteroid anti-inflammatory drugs prevent the recurrence of heterotopic ossification after excision. Arch Orthop Trauma Surg (1990) 0.80
Preoperative cyclooxygenase-2 inhibitor treatment reduces the incidence of heterotopic ossification after hip arthroplasty: six-month follow-up. Anesthesiology (2007) 0.79
Determination of etoricoxib in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionisation. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.79
Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol (2007) 0.78
Sevoflurane requirement during elective ankle day surgery: the effects of etirocoxib premedication, a prospective randomised study. J Orthop Surg Res (2008) 0.77
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74
Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology (2015) 3.73
A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell (2010) 2.37
Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature (2008) 2.30
Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome. Pain (2010) 2.07
Uncomplicated removal of epidural catheters in 4365 patients with international normalized ratio greater than 1.4 during initiation of warfarin therapy. Reg Anesth Pain Med (2011) 2.04
Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J (2007) 2.00
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci U S A (2011) 1.95
Ethnic similarities and differences in the chronic pain experience: a comparison of african american, Hispanic, and white patients. Pain Med (2005) 1.90
A cross-sectional survey on prevalence and risk factors for persistent postsurgical pain 1 year after total hip and knee replacement. Reg Anesth Pain Med (2012) 1.86
The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf (2004) 1.57
Cyclooxygenase-2--10 years later. J Pharmacol Exp Ther (2002) 1.44
Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng (2006) 1.40
Inappropriate perioperative fluid management in children: time for an isotonic solution?! Paediatr Anaesth (2008) 1.39
In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur J Immunol (2006) 1.31
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest (2005) 1.30
Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high-performance liquid chromatography. Biomed Chromatogr (2003) 1.29
Clonidine prolongation of lidocaine analgesia after sciatic nerve block in rats Is mediated via the hyperpolarization-activated cation current, not by alpha-adrenoreceptors. Anesthesiology (2004) 1.28
Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum (2006) 1.27
Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics (2002) 1.23
Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol (2009) 1.23
Retracted Preventing the development of chronic pain after orthopaedic surgery with preventive multimodal analgesic techniques. J Bone Joint Surg Am (2007) 1.21
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. Clin Pharmacokinet (2007) 1.14
Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging (2003) 1.12
Predictors for moderate to severe acute postoperative pain after total hip and knee replacement. Int Orthop (2012) 1.11
A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol (2002) 1.10
Retracted The analgesic efficacy of celecoxib, pregabalin, and their combination for spinal fusion surgery. Anesth Analg (2006) 1.10
Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin Chem (2002) 1.10
Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. J Clin Pharmacol (2007) 1.07
Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats. Reg Anesth Pain Med (2010) 1.05
Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci (2006) 1.05
Lack of awareness of community-acquired adverse drug reactions upon hospital admission : dimensions and consequences of a dilemma. Drug Saf (2003) 1.03
Upregulation of spinal cyclooxygenase-2 in rats after surgical incision. Anesthesiology (2004) 1.03
Gene expression changes in blood after phlebotomy: implications for gene expression profiling. Blood (2002) 1.02
Development of a severity score for CRPS. Pain (2010) 1.02
The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee. Neuromodulation (2014) 1.01
Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses. Pain (2013) 1.00
V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum (2011) 0.98
The mechanisms of intracranial pressure modulation by epidural blood and other injectates in a postdural puncture rat model. Anesth Analg (2002) 0.98
Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice. Arthritis Rheum (2002) 0.96
Combining functional magnetic resonance imaging with mouse genomics: new options in pain research. Neuroreport (2010) 0.96
Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol (2009) 0.96
Imaging of hyperalgesia in rats by functional MRI. Eur J Pain (2006) 0.95
Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. FASEB J (2007) 0.94
Characterization of a new animal model for evaluation and treatment of back pain due to lumbar facet joint osteoarthritis. Arthritis Rheum (2011) 0.94
Stabilization of gene expression profiles in blood after phlebotomy. Clin Chem (2002) 0.94
15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism. Biochem Biophys Res Commun (2003) 0.94
Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol (2006) 0.94
Upregulation of cerebrospinal fluid and peripheral prostaglandin E2 in a rat postoperative pain model. Anesth Analg (2006) 0.93
Paracetamol, ibuprofen, or a combination of both drugs against knee pain: an excellent new randomised clinical trial answers old questions and suggests new therapeutic recommendations. Ann Rheum Dis (2011) 0.93
Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs. J Rheumatol (2011) 0.93
Recent advances in multimodal analgesia. Anesthesiol Clin (2012) 0.93
Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy. Br J Pharmacol (2002) 0.92
Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. FASEB J (2005) 0.91
Prevalence of self-reported pain, joint complaints and knee or hip complaints in adults aged ≥ 40 years: a cross-sectional survey in Herne, Germany. PLoS One (2013) 0.90
Cyclooxygenase-2 inhibition potentiates morphine antinociception at the spinal level in a postoperative pain model. Reg Anesth Pain Med (2002) 0.89
Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans. Clin Pharmacol Ther (2003) 0.88
Simultaneous determination of leflunomide and its active metabolite, A77 1726, in human plasma by high-performance liquid chromatography. Biomed Chromatogr (2003) 0.88
R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells. J Pharmacol Exp Ther (2005) 0.88
Characterization of pain and pharmacologic responses in an animal model of lumbar adhesive arachnoiditis. Spine (Phila Pa 1976) (2005) 0.88
Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal. Nat Clin Pract Rheumatol (2007) 0.87
Kinetics and functional characterization of the glycine receptor alpha2 and alpha3 subunit. Neurosci Lett (2007) 0.87
Effect of acute versus continuous glycemic control on duration of local anesthetic sciatic nerve block in diabetic rats. Reg Anesth Pain Med (2012) 0.87
Intrinsic versus extrinsic vascularization in tissue engineering. Adv Exp Med Biol (2006) 0.87
Pain management for total hip arthroplasty. J Surg Orthop Adv (2014) 0.87
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells. Mol Pharmacol (2004) 0.87
Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor. Eur J Neurosci (2003) 0.87
More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib. Arthritis Rheum (2006) 0.87
Paracetamol and cyclooxygenase inhibition: is there a cause for concern? Ann Rheum Dis (2011) 0.86
Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases. Biochem Biophys Res Commun (2005) 0.86
Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia. Respir Res (2005) 0.86
Retracted Postoperative modulation of central nervous system prostaglandin E2 by cyclooxygenase inhibitors after vascular surgery. Anesthesiology (2006) 0.86
Endogenous opioid inhibition of chronic low-back pain influences degree of back pain relief after morphine administration. Reg Anesth Pain Med (2014) 0.86
Pain and osteoarthritis: new drugs and mechanisms. Curr Opin Rheumatol (2004) 0.86
Extrapleural, submuscular bars placed by bilateral thoracoscopy--a new improvement in modified Nuss funnel chest repair. J Pediatr Surg (2005) 0.86
Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF. Eur J Pharmacol (2006) 0.85
Focus on the COX-1 and COX-2 agents: renal events of nonsteroidal and anti-inflammatory drugs-NSAIDs. Am J Ther (2004) 0.85
Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study. BMJ Open (2013) 0.85
E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions. Br J Clin Pharmacol (2013) 0.85
The rat intervertebral disk degeneration pain model: relationships between biological and structural alterations and pain. Arthritis Res Ther (2011) 0.85
The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation Appropriateness Consensus Committee. Neuromodulation (2014) 0.84
Postoperative pain and analgesic responses are similar in male and female Sprague-Dawley rats. Can J Anaesth (2003) 0.84
Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac. Clin Pharmacol Ther (2003) 0.84
R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells: possible involvement of membrane lipid rafts. Biochem Biophys Res Commun (2004) 0.84
Synergistic effects of the anti-cholinergic R,R-glycopyrrolate with anti-inflammatory drugs. Biochem Pharmacol (2006) 0.83
Can drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacology. Trends Pharmacol Sci (2008) 0.83
Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry. Biomed Chromatogr (2002) 0.83
Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. Biomed Chromatogr (2006) 0.82
A prospective randomized trial of mini-incision posterior and two-incision total hip arthroplasty. Clin Orthop Relat Res (2010) 0.82
Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter organic anion-transporting polypeptide 2A1 expressed in human gastroduodenal mucosa. J Pharmacol Exp Ther (2009) 0.82
Upregulation of dorsal horn microglial cyclooxygenase-1 and neuronal cyclooxygenase-2 after thoracic deep muscle incisions in the rat. Anesth Analg (2008) 0.82
Bioavailability of diclofenac potassium at low doses. Br J Clin Pharmacol (2005) 0.81
Relationship between endogenous opioid function and opioid analgesic adverse effects. Reg Anesth Pain Med (2014) 0.81
Hypoxia induced chemokine expression in nasal epithelial cells: development of an in vitro model for chronic rhinosinusitis. ALTEX (2006) 0.81
N-terminal prohormone brain natriuretic peptide: a biomarker for detecting cardiovascular risks in patients with rheumatoid arthritis or osteoarthritis? Ann Rheum Dis (2007) 0.81
Effect of amiodarone on the plasma levels of metoprolol. Am J Cardiol (2004) 0.80
The appropriate use of neurostimulation: new and evolving neurostimulation therapies and applicable treatment for chronic pain and selected disease states. Neuromodulation Appropriateness Consensus Committee. Neuromodulation (2014) 0.80
The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation Appropriateness Consensus Committee. Neuromodulation (2014) 0.80
Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells. Mol Pharmacol (2003) 0.80